More than 200 MEPs call on European Commission to take action on heart failure

News & Events

26 January 2017
AUTHOR: HFPN Admin

The Heart Failure Policy Network has worked closely with 17 MEPs from 12 countries who launched a new Written Declaration (110/2016) on heart failure in the European Parliament. The campaign ran from 24 October 2016 to 24 January 2017 and secured 234 MEP signatures, making it arguably the largest political campaign ever on heart failure in Europe. The Written Declaration was initiated by the following MEPs:

The initiative also had significant support from organisations across Europe, over 25 European and National groups representing patients, professional groups and NGOs participated in the initiative.

The Written Declaration on Heart Failure requested that the European Commission considered initiatives to:

Despite not receiving enough signatures to pass (European Parliament rules require 376 signatures, or half of all MEPs), the Written Declaration and its associated campaign provided a significant awareness-raising opportunity. Some of the many campaign successes included reaching more than 1.6 million people on Twitter, and the presentation of the signatures to the Maltese Health Minister during the European Parliament’s ENVI committee meeting on 24 January 2017. MEP Edward Czesak (ECR, Poland) also submitted an official Written Question on heart failure to the European Commission.

Find out more about on the Written Declaration project page.

Tagged:

More from News & Events

Strategic consensus on heart failure in Portugal launched
Strategic consensus on heart failure in Portugal launched...
06 October 2020
The HFPN has collaborated with the Institute of Health Sciences of the Catholic University of Portugal to develop a strategic consensus on heart failure in Portugal....
Read article
HFPN participates in Portuguese event on heart failure
HFPN participates in Portuguese event on heart failure...
24 January 2020
The HFPN attended the Annual Meeting of the Heart Failure Working Group of the Portuguese Society of Cardiology....
Read article
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.